Die Joint Programming Initiative zur Antimikrobiellen Resistenz (JPIAMR) hat zum Ziel, Lösungsansätze für die Zunahme antimikrobieller Resistenzen zu finden. Die Ausschreibung legt den Fokus auf die Bekämpfung von antimikrobiellen Resistenzen im Bereich der Human- und Tiergesundheit.
Teilnehmende Länder: Deutschland, Argentinien, Belgien, Frankreich, Italien, die Niederlande, Norwegen, Polen und Schweden.
Über Joint Programming Initiative on Antimicrobial Resistance:
Antibiotics have saved millions of lives from once deadly infectious diseases. But, misuse of antibiotics and other antimicrobials in humans and animals has led to bacteria evolving resistance.To go some way towards tackling Antimicrobial Resistance (AMR), the Joint Programme Initiative on Antimicrobial Resistance (JPIAMR) has identified six priority topics to form a Strategic Research Agenda (SRA). These topics will give the fight against antibiotic resistance a multidimensional approach. These approaches will be translated into new prevention and intervention strategies that improve public health and the wellbeing of populations and deliver economic and societal benefits throughout Europe and beyond. The SRA has truly adopted a ‘One Health’ approach including animals and the environment in its AMR approach.Joint programming is the process by which participating countries define, develop and implement a common strategic research agenda. This agenda is based on the agreed vision on how to address major societal challenges that no individual country is capable of handling by itself. Antimicrobial resistance is one of those challenges. In this context, 19 countries form the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). The aim of this initiative is to develop integrated approaches to pursue unique world-class research on AMR. The outcomes of this research will be translated into new prevention and intervention strategies to improve public health and the wellbeing of populations. It is expected that the results will also lead to economic and societal benefits not only in Europe but also globally.
Weitere Informationen unter: http://www.jpiamr.eu/